New Analysis of COGENT Data Supports Proton Pump Inhibitor Benefit with Low and High Aspirin Doses

    loading  Checking for direct PDF access through Ovid

Abstract

A dedicated analysis of the COGENT trial involving coronary artery disease patients on dual antiplatelet therapy shows comparable risks of gastrointestinal and cardiovascular events between low- and high-dose aspirin, and similar benefits of prophylactic proton pump inhibitor therapy.

Related Topics

    loading  Loading Related Articles